Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6 - PubMed (original) (raw)
Relationship of obesity and visceral adiposity with serum concentrations of CRP, TNF-alpha and IL-6
Hye Soon Park et al. Diabetes Res Clin Pract. 2005 Jul.
Abstract
Objective: To investigate the relationship between serum concentrations of the cytokines C-reactive protein (CRP), tumor necrosis factor (TNF)-alpha, and interleukin (IL)-6, and obesity and visceral adiposity.
Methods: A cross-sectional study of 100 Korean adults free from pre-existing inflammatory disease or cancer was performed. Body mass index (BMI), waist circumference, and serum concentrations of CRP, TNF-alpha and IL-6 were measured. In 46 obese subjects, fat mass was assessed by bioimpedance analysis and abdominal fat distribution was determined by computerized tomography scan.
Results: Overall, serum concentrations of CRP, TNF-alpha and IL-6 were significantly correlated with weight, BMI, waist circumference, hip circumference, and waist-hip ratio. In obese subjects, CRP and IL-6 were significantly correlated with BMI, waist circumference and visceral adipose tissue. Multiple regression analysis showed that CRP was significantly associated with BMI, whereas IL-6 was significantly related with visceral adiposity in obese subjects.
Conclusions: The positive associations of obesity and visceral adiposity with elevated cytokine levels suggest the importance of reducing obesity and visceral adiposity to prevent elevations in cytokine levels.
Similar articles
- Age-related differences in inflammatory markers in men: contribution of visceral adiposity.
Cartier A, Côté M, Lemieux I, Pérusse L, Tremblay A, Bouchard C, Després JP. Cartier A, et al. Metabolism. 2009 Oct;58(10):1452-8. doi: 10.1016/j.metabol.2009.04.025. Metabolism. 2009. PMID: 19595381 - Circulating levels of MCP-1 and IL-8 are elevated in human obese subjects and associated with obesity-related parameters.
Kim CS, Park HS, Kawada T, Kim JH, Lim D, Hubbard NE, Kwon BS, Erickson KL, Yu R. Kim CS, et al. Int J Obes (Lond). 2006 Sep;30(9):1347-55. doi: 10.1038/sj.ijo.0803259. Epub 2006 Mar 14. Int J Obes (Lond). 2006. PMID: 16534530 - Association between inflammatory and obesity markers in a Swiss population-based sample (CoLaus Study).
Marques-Vidal P, Bochud M, Bastardot F, Lüscher T, Ferrero F, Gaspoz JM, Paccaud F, Urwyler A, von Känel R, Hock C, Waeber G, Preisig M, Vollenweider P. Marques-Vidal P, et al. Obes Facts. 2012;5(5):734-44. doi: 10.1159/000345045. Epub 2012 Oct 23. Obes Facts. 2012. PMID: 23108472 - Stop feeding cancer: pro-inflammatory role of visceral adiposity in liver cancer.
Zhao J, Lawless MW. Zhao J, et al. Cytokine. 2013 Dec;64(3):626-37. doi: 10.1016/j.cyto.2013.09.009. Epub 2013 Oct 11. Cytokine. 2013. PMID: 24120848 Review. - [Relation of serum levels of C-reactive protein to anthropometric meaurements; a sustematic review of studies in South America].
Ramírez Alvarado MM, Sánchez Roitz C. Ramírez Alvarado MM, et al. Nutr Hosp. 2012 Jul-Aug;27(4):971-7. doi: 10.3305/nh.2012.27.4.5792. Nutr Hosp. 2012. PMID: 23165532 Review. Spanish.
Cited by
- Clinical significance of early kinetics of C‑reactive protein in patients with advanced urothelial carcinoma treated with pembrolizumab: Flare response and baseline levels predict oncological outcomes.
Tomisaki I, Harada M, Sakano S, Terado M, Hamasuna R, Harada S, Matsumoto H, Akasaka S, Nagata Y, Minato A, Harada KI, Fujimoto N. Tomisaki I, et al. Oncol Lett. 2024 Oct 11;28(6):603. doi: 10.3892/ol.2024.14736. eCollection 2024 Dec. Oncol Lett. 2024. PMID: 39525607 Free PMC article. - Life Essentials 8 score and risk of metabolic syndrome: A dose-response analysis in the US population.
Jia F, Sun J, Liu X, Liu Y. Jia F, et al. PLoS One. 2024 Oct 31;19(10):e0312674. doi: 10.1371/journal.pone.0312674. eCollection 2024. PLoS One. 2024. PMID: 39480760 Free PMC article. - Pharmacology of P2X Receptors and Their Possible Therapeutic Potential in Obesity and Diabetes.
Cabral-García GA, Cruz-Muñoz JR, Valdez-Morales EE, Barajas-Espinosa A, Liñán-Rico A, Guerrero-Alba R. Cabral-García GA, et al. Pharmaceuticals (Basel). 2024 Sep 28;17(10):1291. doi: 10.3390/ph17101291. Pharmaceuticals (Basel). 2024. PMID: 39458933 Free PMC article. Review. - Edodes Cultured Extract Regulates Immune Stress During Puberty and Modulates MicroRNAs Involved in Mammary Gland Development and Breast Cancer Suppression.
Yasavoli-Sharahi H, Shahbazi R, Alsadi N, Robichaud S, Kambli DB, Izadpanah A, Mohsenifar Z, Matar C. Yasavoli-Sharahi H, et al. Cancer Med. 2024 Oct;13(19):e70277. doi: 10.1002/cam4.70277. Cancer Med. 2024. PMID: 39382253 Free PMC article. - 1α,25-Dihydroxyvitamin D Downregulates Adipocyte Impact on Breast Cancer Cell Migration and Adipokine Release.
Yum C, Andolino C, Larrick B, Sheeley MP, Teegarden D. Yum C, et al. Nutrients. 2024 Sep 18;16(18):3153. doi: 10.3390/nu16183153. Nutrients. 2024. PMID: 39339753 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous